Obasa Adetayo E, Botes Marietjie, Kleinsmidt Anita, Staunton Ciara
Registrar Research Support Office, Research and Internationalisation Development and Support, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Stellenbosch University Centre for Research on Evaluation Science and Technology, Stellenbosch, South Africa.
Dev World Bioeth. 2025 Jul 18. doi: 10.1111/dewb.70001.
Mpox, first identified in captive monkeys in 1958 and recognized in humans by 1970 in the Democratic Republic of Congo, was historically confined to sporadic zoonotic outbreaks in Central and West Africa. These outbreaks, often driven by rodent-to-human transmission in resource-limited settings, reflect persistent systemic health disparities. In recent years, mpox has also been reported in high-income countries (including the United States, United Kingdom and Europe), underscoring its global health implications beyond traditionally endemic regions. This article examines the mpox outbreak through the lens of public health ethics, evaluating how core ethical frameworks-justice (encompassing equitable vaccine distribution and addressing health inequities), solidarity and respect for rights (including intellectual property considerations)-shape outbreak management strategies. These strategies are ensuring equitable access to vaccines and therapeutics amid intellectual property barriers, combating stigma and misinformation through transparent risk communication and fostering international solidarity in coordinating responses. The analysis highlights how neglect of these principles exacerbates existing disparities and undermines the effectiveness of interventions. Integrating ethical principles into outbreak responses is critical for building public trust, accountability and community resilience. By distilling lessons from the mpox response, this article contributes to ongoing debates in public health ethics and outbreak preparedness, arguing that ethically grounded approaches are essential for fair and effective management of future public health crises.
猴痘于1958年在圈养猴子中首次被发现,并于1970年在刚果民主共和国被确认存在于人类中,历史上它一直局限于中非和西非的散发性人畜共患病疫情。这些疫情往往是由资源有限地区的啮齿动物向人类传播引发的,反映了持续存在的系统性健康差距。近年来,猴痘在高收入国家(包括美国、英国和欧洲)也有报道,这凸显了其在传统流行地区之外对全球健康的影响。本文从公共卫生伦理的角度审视猴痘疫情,评估核心伦理框架——正义(包括公平的疫苗分配和解决健康不平等问题)、团结以及对权利的尊重(包括知识产权考量)——如何塑造疫情管理策略。这些策略包括在知识产权壁垒下确保公平获取疫苗和治疗方法,通过透明的风险沟通消除污名化和错误信息,并在协调应对措施中促进国际团结。分析强调了忽视这些原则如何加剧现有差距并削弱干预措施的有效性。将伦理原则纳入疫情应对对于建立公众信任、问责制和社区复原力至关重要。通过提炼猴痘应对中的经验教训,本文为公共卫生伦理和疫情防范方面正在进行的辩论做出贡献,认为基于伦理的方法对于公平有效地管理未来公共卫生危机至关重要。